期刊文献+

携带结核杆菌Ag85B靶细胞的构建、鉴定及应用 被引量:1

Construction,identification and application of the target cells carrying Ag85B antigen of Mycobacterium tuberculosis
暂未订购
导出
摘要 目的构建表达结核分枝杆菌分泌蛋白Ag85B的靶细胞以便评定结核疫苗的特异性细胞毒(CTL)作用。方法将携带有Ag85B基因的重组质粒pTB30s转入小鼠骨髓瘤细胞(SP2/0),用RT-PCR及免疫组化染色法鉴定阳性克隆细胞胞内的Ag85B基因转录和蛋白表达水平;同时,用接种过BCG,pTB30s或生理盐水(NS)小鼠脾脏单个核细胞作为效应细胞,G418高压筛选的阳性克隆细胞为靶细胞,用MTT法检测各组CTL杀伤活性。结果RT-PCR以及免疫组化结果显示,阳性细胞能稳定表达Ag85B。CTL杀伤实验:BCG、pTB30s及NS对照组杀伤率分别为28.14%、45.18%和5.13%。结论含有Ag85B靶细胞构建成功及应用,为研究结核疫苗的免疫效果提供了较好的研究手段。 To construct the target cells that carry Ag85B antigen of Mycobacterium tuberculosis for the evaluation of the function of cytotoxic T lymphocytes (CTL) induced by vaccine for tuberculosis, the recombinant plasmid pTB30s carrying ag85B gene was transfected to mouse myeloma cell line SP2/0 cells with lipofectamine, and the positive clones were cloned with high concentration of G418. The transcription and expression levels of ag85B gene were identified by RT-PCR and immunohistochemical stain. Meanwhile, the cytotoxic activities of CTLs were assayed in various groups of mice by means of MTT assay, in which the splenic mononucleated cells of mice immunized with BCG, pTB30s or normal saline were used as effector cells, and the positive clone cells screened with high concentration of G418 were used as target cells. The experimental results showed that the positive clones screened could express stably the Ag85B antigen as demonstrated by RT-PCR and immunohistochemical staining. The cytotoxic rates of the effector cells on the target cells in group of mice immunized with BCG, pTB30s and the control group of mice with injection of saline were 28.14%, 45.18% and 5.13% respectively. It is evident that the target cells carrying Ag65B antigen was successfully constructed, by which it can be used to evaluate the function of CTLs induced by tuberculosis vaccine.
出处 《中国人兽共患病学报》 CAS CSCD 北大核心 2007年第3期214-217,共4页 Chinese Journal of Zoonoses
基金 重庆市教委资助项目(渝教科〔2004〕12号文) 重庆医科大学科技创新资助项目(CX200204)
关键词 结核分枝杆菌 AG85B 特异性CTL杀伤活性 Mycobacterium tuberculosis antibody 85B specificity CTL killing ability
  • 相关文献

参考文献8

  • 1World Health Organization.Health system:improving performance[R].World health report,2000:152-164.
  • 2范雄林,徐志凯,李元,薛莹,李别虎,白光春.结核分支杆菌Ag85B分泌蛋白基因疫苗的构建和免疫原性的研究[J].中华结核和呼吸杂志,2001,24(9):548-550. 被引量:22
  • 3骆旭东,朱道银,陈全,蒋英,江山,杨春.Ag85B DNA疫苗对鼠结核分枝杆菌感染的保护作用[J].中华传染病杂志,2005,23(2):118-120. 被引量:4
  • 4Ko HJ,Ko SY,Kim YJ,et al.Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding Mycobacterial antigen Ag85B[J].Infection and Immunity,2005,73 (9):5666-5674.
  • 5Sud D,Bigbee C,Flynn JL,et al.Contribution of CD8^+ T cells to control of Mycobacterium tuberculosis infection[J].J Immunol 2006,176(7):4296-4314.
  • 6Feng CG,Palendira U,Demangel C,et al.Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis[J].Infect Immun,2001,69(6):4174-4176.
  • 7Cai H,Yu DH,Hu XD,et al.A combined DNA vaccineprime,BCG-boost strategy results in better protection against Mycobacterium bovis challenge[J].DNA Cell Biol,2006,25(8):438-447.
  • 8Lee BY,Horwitz MA.Identification of macrophage and stressinduced proteins of Mycobacterium tuberculosis[J].J Clin Invest,1995,96:245-249.

二级参考文献14

  • 1范雄林,细胞与分子免疫学杂志,2000年,16卷,314页
  • 2Kamath A T,Infect Immun,1999年,67卷,1702页
  • 3Li Z M,Infect Immun,1999年,67卷,4780页
  • 4Harth G,Infect Immun,1996年,64卷,3038页
  • 5Centers for Disease Control and Prevention. Development of new vaccines for tuberculosis. Recommendations of the Advisory Council for the Elimination of Tuberculosis (ACET).Morb Mortal Wkly Rep, 1998,47:1-6.
  • 6Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet, 1995,347 : 340.
  • 7Robinson HL, Torres CA. DNA vaccines. Semin Immunol,1997, 9: 271-283.
  • 8Hasan UA, Abai AM, Harper DR, et al. Nucleic acid immunization : concepts and techniques associated with third generation vaccines. J Immunol Methods, 1999,229: 1-22.
  • 9Rosenfeld ME, Curiel DT. Gene therapy strategies for novel cancer therapeutics. Curr Opin Oncol, 1996,8:72-77.
  • 10Lobell A, Weissert R, Storh MK, et al. Vaccination with DNA endcoding an immunodominant myelin basic protein peptide targeted to Fc of immunoglobin G suppress experimental autoimmune encephalomyelitis. J Exp Med, 1998: 1543-1548.

共引文献24

同被引文献9

  • 1卢贤瑜,魏江.小鼠胃内接种BCG后细菌的定植及抗结核细胞免疫功能的探讨[J].中国免疫学杂志,2005,21(4):304-307. 被引量:3
  • 2HuaWANG,WeiWEI,Sheng-yiZHANG,Yu-xianSHEN,Ni-pingWANG,LiYUE,Shu-yunXU.Melatonin-selenium nanoparticles protects liver against immunological injury induced by bacillus Calmette-Guérin and lipopolysaccharide[J].Acta Pharmacologica Sinica,2005,26(6):745-752. 被引量:3
  • 3Dietrich G,Viret JF,Hess J.Mycobacterium bovis BCG-based vaccines against tuberculosis:novel developments[J].Vaccine,2003;21 (7-8) :667-670.
  • 4Kandil OM,Abou-Zeina HA. Effect of parenteral vitamin E and selenium supplementation on immune status of dogs vaccinated with subunit and somatic antigens against Taenia hydatigena[J].Egypt Soc Parasitol, 2005 ; 35 ( 2 ) : 537-550.
  • 5Hawkes wc,Kelley DS,Taylor PC.The effects of dietary selenium on the immune system in healthy men[J].Biol Trace Elem Res, 2001;81(3):189-213.
  • 6Broome CS,McArdle F,Kyle JA,et al. An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status[J].Am J Clin Nutr,2004;80(1): 154- 162.
  • 7Canaday DH,Wilkinson RJ,Li Q,et aI.CD4+ and CD8+T cells kill intracellular Mycobac terium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism[J]. J Immunol,2001;167(5): 2734-2742.
  • 8Sud D,Bigbee C,Flynn JL,et al. Contribution of CD8+ T cells to control of Mycobacterium tuberculosis infection [J].J Immunol, 2006; 176(7):4296-4314.
  • 9Worku S,Hoft DF. Differential effects of control and antigenspecific T cells on intracellular Mycobacterial growth[J]. Infect Immun,2003;71 (4) : 1763-1773.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部